OMERS Administration Corp’s Corcept Therapeutics CORT Stock Holding History

OMERS Administration Corp’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Buy	+27,200	New	+$1.02M	0.01%	633
2025 Q4	–	Sell	-8,700	Closed	-$723K	–	1112
2025 Q3	$723K	Buy	+8,700	New	+$630K	0.01%	649
2025 Q1	–	Sell	-44,500	Closed	-$2.24M	–	1051
2024 Q4	$2.24M	Sell	44,500 -52,900	-54%	-$2.77M	0.02%	301
2024 Q3	$4.51M	Sell	97,400 -20,900	-18%	-$743K	0.04%	174
2024 Q2	$3.84M	Buy	118,300 +64,100	+118%	+$1.76M	0.04%	192
2024 Q1	$1.37M	Hold	54,200	–	–	0.02%	143
2023 Q4	$1.76M	Buy	+54,200	New	+$1.49M	0.02%	117
2023 Q2	–	Sell	-339,000	Closed	-$7.34M	–	243
2023 Q1	$7.34M	Buy	+339,000	New	+$7.43M	0.11%	71

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

OMERS Administration Corp's CORT Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 27,200 shares worth $1.1M. The stake represents 0.01% of the portfolio and ranks #633 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in CORT as recently as Q3 2025.

OMERS Administration Corp first reported a position in CORT in Q1 2023 and has held it in 8 quarters since. The position peaked at $7.34M in Q1 2023. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

OMERS Administration Corp held 27,200 shares of Corcept Therapeutics worth $1.1M as of Q1 2026.
Corcept Therapeutics was a new OMERS Administration Corp position in Q1 2026.
Corcept Therapeutics made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #633 holding.
OMERS Administration Corp first reported a position in Corcept Therapeutics in Q1 2023 and has held it in 8 quarters since.
OMERS Administration Corp's Corcept Therapeutics position peaked at $7.34M in Q1 2023.
351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.